REDUCED JOINT SYNOVITIS ASSESSMENT VERSUS THE GLOBAL EULAR OMERACT SYNOVITIS SCORE (GLOESS) TO PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: EXPLORATORY RESULTS FROM THE ULTIMATE TRIAL
D'Agostino MA, Boers M, Schett G, Conaghan PG, Naredo E, Mandl P, Carron P, Backhaus M, Lopez-Rodriguez A, Hanova P, Goyanka P, Sahoo BG, Gaillez C, Bao W (2022)
Publication Type: Conference contribution
Publication year: 2022
Journal
Publisher: BMJ PUBLISHING GROUP
City/Town: LONDON
Pages Range: 195-196
Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES
DOI: 10.1136/annrheumdis-2022-eular.561
Authors with CRIS profile
Involved external institutions
University of Leeds
United Kingdom (GB)
Park-Klinik Weißensee
Germany (DE)
Novartis AG
Switzerland (CH)
Vrije Universiteit Amsterdam (VU) / University Amsterdam
Netherlands (NL)
Medizinische Universität Wien
Austria (AT)
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Italy (IT)
Hospital Universitario Fundación Jiménez Díaz
Spain (ES)
University Hospital Ghent
Belgium (BE)
United Kingdom (GB)
Park-Klinik Weißensee
Germany (DE)
Novartis AG
Switzerland (CH)
Vrije Universiteit Amsterdam (VU) / University Amsterdam
Netherlands (NL)
Medizinische Universität Wien
Austria (AT)
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Italy (IT)
Hospital Universitario Fundación Jiménez Díaz
Spain (ES)
University Hospital Ghent
Belgium (BE)
How to cite
APA:
D'Agostino, M.A., Boers, M., Schett, G., Conaghan, P.G., Naredo, E., Mandl, P.,... Bao, W. (2022). REDUCED JOINT SYNOVITIS ASSESSMENT VERSUS THE GLOBAL EULAR OMERACT SYNOVITIS SCORE (GLOESS) TO PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: EXPLORATORY RESULTS FROM THE ULTIMATE TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 195-196). LONDON: BMJ PUBLISHING GROUP.
MLA:
D'Agostino, M. A., et al. "REDUCED JOINT SYNOVITIS ASSESSMENT VERSUS THE GLOBAL EULAR OMERACT SYNOVITIS SCORE (GLOESS) TO PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: EXPLORATORY RESULTS FROM THE ULTIMATE TRIAL." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2022. 195-196.
BibTeX: Download